Brief: Janux Therapeutics reports Q4 collaboration revenue USD 2.845 million
10/03/2023 21:02
Mar 10 (Reuters) - Janux Therapeutics Q4 net income USD -16.065 million. * Q4 collaboration revenue USD 2.845 million * Q4 operating expenses USD 21.111 million * Q4 operating income USD -18.266 million * Q4 EPS USD -0.39